Ungual and Transungual drug delivery

References

• Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. (1999). Drug permeation through the three layers of the human nail plate. J Pharm Pharmacol, 51:271–278.
   PubMed Web of Science ®Google Scholar
• Lynch MH, O’Guin WM, Hardy C, Mak L, Sun TT. (1986). Acidic and basic hair/nail (“hard”) keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to “soft” keratins. J Cell Biol, 103:2593–2606.
   PubMed Web of Science ®Google Scholar
• Murdan S. (2002). Drug delivery to the nail following topical application. Int J Pharm, 236:1–26.
   PubMed Web of Science ®Google Scholar
• Walters KA, Flynn GL. (1983). Permeability characteristics of the human nail plate. Int J Cosmet Sci, 5:231–246.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al. (2000). A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol, 43:641–648.
   PubMed Web of Science ®Google Scholar
• Sigureirsson, Steingrimsson. (2004). Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol, 18:48–51.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Baran R. (2003). Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol, 149 Suppl 65:1–4.
   PubMed Web of Science ®Google Scholar
• Niewerth M, Korting HC. (1999). Management of onychomycoses. Drugs, 58:283–296.
   PubMed Web of Science ®Google Scholar
• de Berker D. (2009). Management of psoriatic nail disease. Semin Cutan Med Surg, 28:39–43.
   PubMed Web of Science ®Google Scholar
• Repka MA, O’Haver J, See CH, Gutta K, Munjal M. (2002). Nail morphology studies as assessments for onychomycosis treatment modalities. Int J Pharm, 245:25–36.
   PubMed Web of Science ®Google Scholar
• Scher RK. (1999). Onychomycosis: therapeutic update. J Am Acad Dermatol, 40:21–26.
   PubMed Web of Science ®Google Scholar
• Brown MB, Khengar RH, Turner RB, Forbes B, Traynor MJ, Evans CR et al. (2009). Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement. Int J Pharm, 370:61–67.
   PubMed Web of Science ®Google Scholar
• Hao J, Li SK. (2008). Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. J Pharm Sci, 97:893–905.
   PubMed Web of Science ®Google Scholar
• Murthy SN, Vaka SR, Sammeta SM, Nair AB. (2009). TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers. J Pharm Sci, 98:4264–4271.
   PubMed Web of Science ®Google Scholar
• Murthy SN, Waddell DC, Shivakumar HN, Balaji A, Bowers CP. (2007). Iontophoretic permselective property of human nail. J Dermatol Sci, 46:150–152.
   PubMed Web of Science ®Google Scholar
• Narasimha Murthy S, Wiskirchen DE, Bowers CP. (2007). Iontophoretic drug delivery across human nail. J Pharm Sci, 96:305–311.
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Ganem-Quintanar A, Tapia-Olguín P, Kalia YN, Buri P. (1998). The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail. Drug Dev Ind Pharm, 24:685–690.
   PubMed Web of Science ®Google Scholar
• Smith KA, Hao J, Li SK. (2009). Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail. Pharm Res, 26:1446–1455.
   PubMed Web of Science ®Google Scholar
• Smith KA, Hao J, Li SK. (2010). Influence of pH on transungual passive and iontophoretic transport. J Pharm Sci, 99:1955–1967.
   PubMed Web of Science ®Google Scholar
• Vignardet C, Guillaume YC, Friedrich J, Millet J. (1999). A first order experimental design to assess soluble proteins released by a new keratinase from Doratomyces microsporus on human substrates. Int J Pharm, 191:95–102.
   PubMed Web of Science ®Google Scholar
• Mertin D, Lippold BC. (1997). In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy. J Pharm Pharmacol, 49:866–872.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Komatsu T, Sumi M, Numajiri S, Miyamoto M, Kobayashi D et al. (2004). In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci, 21:471–477.
   PubMed Web of Science ®Google Scholar
• Malhotra GG, Zatz JL. (2002). Investigation of nail permeation enhancement by chemical modification using water as a probe. J Pharm Sci, 91:312–323.
   PubMed Web of Science ®Google Scholar
• Vejnovic I, Simmler L, Betz G. (2010). Investigation of different formulations for drug delivery through the nail plate. Int J Pharm, 386:185–194.
   PubMed Web of Science ®Google Scholar
• Nair AB, Chakraborty B, Murthy SN. (2010). Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv, 7:407–414.
   PubMedGoogle Scholar
• Nair AB, Kim HD, Davis SP, Etheredge R, Barsness M, Friden PM et al. (2009). An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res, 26:2194–2201.
   PubMed Web of Science ®Google Scholar
• Nair AB, Sammeta SM, Vaka SR, Narasimha Murthy S. (2009). A study on the effect of inorganic salts in transungual drug delivery of terbinafine. J Pharm Pharmacol, 61:431–437.
   PubMed Web of Science ®Google Scholar
• Nair AB, Vaka SR, Sammeta SM, Kim HD, Friden PM, Chakraborty B et al. (2009). Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci, 98:1788–1796.
   PubMed Web of Science ®Google Scholar
• Walters KA, Flynn GL, Marvel JR. (1985). Physicochemical characterization of the human nail: solvent effects on the permeation of homologous alcohols. J Pharm Pharmacol, 37:771–775.
   PubMed Web of Science ®Google Scholar
• Marro D, Guy RH, Delgado-Charro MB. (2001). Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release, 70:213–217.
   PubMed Web of Science ®Google Scholar
• de Berker D. (2009). Clinical practice. Fungal nail disease. N Engl J Med, 360:2108–2116.
   PubMed Web of Science ®Google Scholar
• Neev J, Nelson JS, Critelli M, McCullough JL, Cheung E, Carrasco WA et al. (1997). Ablation of human nail by pulsed lasers. Lasers Surg Med, 21:186–192.
   PubMed Web of Science ®Google Scholar
• Salter SA, Ciocon DH, Gowrishankar TR, Kimball AB. (2006). Controlled nail trephination for subungual hematoma. Am J Emerg Med, 24:875–877.
   PubMed Web of Science ®Google Scholar
• Ciocon D, Gowrishankar TR, Herndon T, Kimball AB. (2006). How low should you go: novel device for nail trephination. Dermatol Surg, 32:828–833.
   PubMed Web of Science ®Google Scholar
• Boker A, Ciocon D, Kimbell A. (2007). A randomized, double-blind placebo-controlled, pilot study of 1% terbinafine cream applied twice daily and delivered via nail plate microporation for the treatment of subungual toenail trephination. J Am Acad Dermatol, 56, AB 114.
   Web of Science ®Google Scholar
• Murdan S. (2008). Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv, 5:1267–1282.
   PubMed Web of Science ®Google Scholar
• Khengar RH, Jones SA, Turner RB, Forbes B, Brown MB. (2007). Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers. Pharm Res, 24:2207–2212.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu JC, Wang JCT, De Doncker P. (1999). Nail penetration. Focus on topical delivery of antifungal drugs for onychomycosis treatment. In Bronaugh RL, Maibach HI, eds. Percutaneous absorption Drugs-Cosmetics-Mechanisms-Methodology. NewYork: Marcel Dekker Inc., 759–787.
   Google Scholar
• Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. (1998). Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate. Chem Pharm Bull, 46:1797–1802.
   PubMed Web of Science ®Google Scholar
• Baran R, Tosti A. (2002). Chemical avulsion with urea nail lacquer. J Dermatolog Treat, 13:161–164.
   PubMed Web of Science ®Google Scholar
• Mohorcic M, Torkar A, Friedrich J, Kristl J, Murdan S. (2007). An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int J Pharm, 332:196–201.
   PubMed Web of Science ®Google Scholar
• Hay RJ, Clayton YM, Moore MK. (1987). A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol, 12:175–177.
   PubMed Web of Science ®Google Scholar
• Hui X, Shainhouse Z, Tanojo H, Anigbogu A, Markus GE, Maibach HI et al. (2002). Enhanced human nail drug delivery: nail inner drug content assayed by new unique method. J Pharm Sci, 91:189–195.
   PubMed Web of Science ®Google Scholar
• Hui X, Baker SJ, Wester RC, Barbadillo S, Cashmore AK, Sanders V et al. (2007). In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. J Pharm Sci, 96:2622–2631.
   PubMed Web of Science ®Google Scholar
• Suringa DW. (1970). Treatment of superficial onychomycosis with topically applied glutaraldehyde. A preliminary study. Arch Dermatol, 102:163–167.
   PubMed Web of Science ®Google Scholar
• Marty J-L. (1995). Amorolfine nail lacquer: a novel formulation. J Eur Acad of Dermatol Venereol, 4 (Suppl 1) S17–S21.
   Google Scholar
• Franz TJ. (1992). Absorption of amorolfine through human nail. Dermatology (Basel), 184 Suppl 1:18–20.
   PubMedGoogle Scholar
• Gupta AK, Fleckman P, Baran R. (2000). Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol, 43:S70–S80.
   PubMed Web of Science ®Google Scholar
• Polak A. (1993). Amorolfine: A review of its mode of action and in vitro and in vivo antifungal activity. J Am Assoc South East Asia, 9 (Suppl 4):11–18.
   Google Scholar
• Hui X, Chan TC, Barbadillo S, Lee C, Maibach HI, Wester RC. (2003). Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane. J Pharm Sci, 92:142–148.
   PubMed Web of Science ®Google Scholar
• Shivakumar HN, Vaka SR, Madhav NV, Chandra H, Murthy SN. (2010). Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci, 99:4267–4276.
   PubMed Web of Science ®Google Scholar
• Avner S, Nir N, Henri T. (2005). Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. J Dermatolog Treat, 16:327–330.
   PubMed Web of Science ®Google Scholar
• Van Hoogdalem EJ, van den Hoven WE, Trepstra IJ, van Zijtveld J, Verschoor JSC, Visser JN. (1997). Nail penetration of antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine. Eur J Pharm Sci, 5:119–127.
   Web of Science ®Google Scholar
• Hui X, Wester RC, Barbadillo S, Lee C, Patel B, Wortzmman M et al. (2004). Ciclopirox delivery into the human nail plate. J Pharm Sci, 93:2545–2548.
   PubMed Web of Science ®Google Scholar
• Repka MA, Mididoddi PK, Stodghill SP. (2004). Influence of human nail etching for the assessment of topical onychomycosis therapies. Int J Pharm, 282:95–106.
   PubMed Web of Science ®Google Scholar
• Obadiah J, Scher R. (2002). Nail disorders: unapproved treatments. Clin Dermatol, 20:643–648.
   PubMed Web of Science ®Google Scholar
• Baden HP. (1994). Treatment of distal onychomycosis with avulsion and topical antifungal agents under occlusion. Arch Dermatol, 130:558–559.
   PubMed Web of Science ®Google Scholar
• Mididoddi PK, Repka MA. (2007). Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm, 66:95–105.
   PubMed Web of Science ®Google Scholar
• Susilo R, Korting HC, Greb W, Strauss UP. (2006). Nail penetration of sertaconazole with a sertaconazole-containing nail patch formulation. Am J Clin Dermatol, 7:259–262.
   PubMed Web of Science ®Google Scholar
• Warshaw EM, St Clair KR. (2005). Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. J Am Acad Dermatol, 53:717–720.
   PubMed Web of Science ®Google Scholar
• Bindra, Rattan Lal, Singh, Anil Kumar, Shawl, Abdul Sami, Kumar, Sushil. (2001). Anti-fungal herbal formulation for treatment of human nails fungus and process thereof. United States Patent No.6296838.
   Google Scholar